CEO/President, 10% Owner of Bruker BioSciences Corp. (BRKR, Financial) Frank H Laukien buys 100,000 shares of BRKR on 03/17/2010 at an average price of $14.36 a share.
Bruker Biosciences Corp. has a market cap of $2.4 billion; its shares were traded at around $14.61 with a P/E ratio of 29.3 and P/S ratio of 2.2.
BRKR is in the portfolios of Chuck Royce of Royce& Associates, Steven Cohen of SAC Capital Advisors, Jim Simons of Renaissance Technologies LLC.
Bruker Biosciences Corp. has a market cap of $2.4 billion; its shares were traded at around $14.61 with a P/E ratio of 29.3 and P/S ratio of 2.2.
BRKR is in the portfolios of Chuck Royce of Royce& Associates, Steven Cohen of SAC Capital Advisors, Jim Simons of Renaissance Technologies LLC.
CEO Recent Trades:
- Buy:: CEO/President, 10% Owner Frank H Laukien bought 100,000 shares of BRKR stock on 03/15/2010 at the average price of 14, the price of the stock has increased by 4.36% since.
- Buy:: CEO/President, 10% Owner Frank H Laukien bought 3,570 shares of BRKR stock on 12/14/2009 at the average price of 11.2, the price of the stock has increased by 30.45% since.
- Buy:: CEO/President, 10% Owner Frank H Laukien bought 100,000 shares of BRKR stock on 09/22/2009 at the average price of 9.85, the price of the stock has increased by 48.32% since.
Directors and Officers Recent Trades:
- Sell:: Director, 10% Owner Dirk D Laukien sold 2,000,000 shares of BRKR stock on 03/03/2010 at the average price of 12.95, the price of the stock has increased by 12.82% since.
- Sell:: Director, 10% Owner Dirk D Laukien sold 2,000,000 shares of BRKR stock on 12/01/2009 at the average price of 10.67, the price of the stock has increased by 36.93% since.
- Sell:: Secretary Richard M Stein sold 3,000 shares of BRKR stock on 11/20/2009 at the average price of 11.65, the price of the stock has increased by 25.41% since.
- Sell:: 10% Owner Isolde Laukien sold 3,000,000 shares of BRKR stock on 09/22/2009 at the average price of 9.36, the price of the stock has increased by 56.09% since.
